patent

Amgen’s cancer biosimilars stay on US market as court battle with Roche ends

https://pharmaphorum.com/news/amgens-cancer-biosimilars-stay-on-us-market-as-court-battle-with-roche-ends/

Amgen wins latest round in legal tussle over Enbrel patents

https://pharmaphorum.com/news/amgen-wins-latest-round-in-legal-tussle-over-enbrel-patents/

AbbVie won’t enforce patents for COVID-19 drug candidate Kaletra

https://pharmaphorum.com/news/abbvie-wont-enforce-patents-for-covid-19-drug-candidate-kaletra/

Biogen claims victory in patent dispute with Mylan over MS drug Tecfidera

https://pharmaphorum.com/news/biogen-claims-victory-in-patent-dispute-with-mylan-over-ms-drug-tecfidera/

Alexion’s biosimilar-blocking EU patent play for Soliris fails

https://pharmaphorum.com/news/alexions-biosimilar-blocking-eu-patent-play-for-soliris-fails/

Celgene gets US patent let-off ahead of BMS merger

https://pharmaphorum.com/news/celgene-gets-us-patent-let-off-ahead-of-bms-merger/

Indivior hit hard as generic Suboxone defence crumbles

https://pharmaphorum.com/news/indivior-hit-hard-as-generic-suboxone-defence-crumbles/

Pfizer hit by UK Supreme Court ruling on Lyrica patent

https://pharmaphorum.com/news/pfizer-hit-by-uk-supreme-court-ruling-on-lyrica-patent/

Biogen gets go-ahead for EU Humira launch in October

https://pharmaphorum.com/sales-marketing/biogen-gets-go-ahead-eu-humira-launch-october/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search